Skip to content
HowShorted

Damora Therapeutics, Inc. short interest in 2021

In 2021, Damora Therapeutics, Inc.'s disclosed short interest ran from 0.04% of shares outstanding on 15 Jan 2021 to 0.18% on 15 Dec 2021, a change of +0.14 percentage points. The year's high was 1.68% on 30 Jun 2021 and its low 0.02% on 12 Feb 2021, averaging 0.45% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.01 days on 30 Apr 2021. Full history: Damora Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Damora Therapeutics, Inc. in 2021

2021 in figures

Start of year
0.04% (15 Jan 2021)
End of year
0.18% (15 Dec 2021)
Change
+0.14 pp
High
1.68% (30 Jun 2021)
Low
0.02% (12 Feb 2021)
Average
0.45%
Highest days to cover
3.01 (30 Apr 2021)
SEC filings marked
5

Every report in 2021

Damora Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20210.04%1.00results (8-K)
29 Jan 20210.04%1.00
12 Feb 20210.02%1.00
31 Mar 20210.28%1.3210-K filed
15 Apr 20210.49%2.42
30 Apr 20210.48%3.01
14 May 20210.51%2.6110-Q filed
28 May 20210.55%1.22
15 Jun 20211.07%1.00
30 Jun 20211.68%1.00
15 Jul 20211.00%1.00
30 Jul 20210.73%1.00
13 Aug 20210.53%1.0010-Q filed
31 Aug 20210.39%1.00
15 Sep 20210.33%1.37
30 Sep 20210.19%1.00
15 Oct 20210.11%1.00
15 Nov 20210.22%1.0010-Q filed
30 Nov 20210.22%1.00
15 Dec 20210.18%1.00

See also: Damora Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.